We hereby submit the corrigendum to the Extra-Ordinary General Meeting to be held on October 23, 2026.

Date: October 13, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai –400001 Scrip Code: 541096 Subject: Corrigendum to the notice of Extraordinary General Meeting of the Members of the Company (EGM Notice) scheduled to be held on Friday 23rd October 2026 at 11:30 AM. through Video Conferencing / Other Audio-Visual Means. Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and in furtherance to our intimation letter dated October 01, 2026, wherein the Company has informed the exchange about the Extraordinary General Meeting ("EGM") of the members of the Company which is scheduled to be held on Friday 23rd October 2026 at 11:30 A.M through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") to transact the business as listed in the notice of the EGM. In this regard we would like to mention that regarding Item No. 1 of the aforesaid EGM Notice, the Company had (cid:976)iled application with BSE Limited (“BSE”) seeking In-principle approval in relation to the proposed Preferential Issue of Equity Shares for which the approval of the shareholders is being sought. Thereafter, BSE Limited has directed the Company to issue a corrigendum to the Notice giving additional disclosures on appointment of Monitoring Agency. In compliance with the above, the attached Corrigendum is being issued.Except as detailed in the attached Corrigendum, all other contents of the EGM Notice intimation dated October 01, 2026 shall remain unchanged. This Corrigendum will also be available on the website of the Company at the web link https://www.bplindia.in/investor-general-metting.html This is for your information and records. Thanking You. For, Bharat Parenterals Limited Sharmin Soni Company Secretary & Compliance Officer ICSI Membership Number: A-75694 Encls. As above CORRIGENDUM TO THE NOTICE OF EXTRAORDINARY GENERAL MEETING (EGM) TO BE HELD ON OCTOBER 23, 2026. Dear Members, This is in continuation to the Notice of the EGM dated September 29, 2026 issued by the Company for the proposed EGM scheduled to held on Friday, October 23, 2026 (‘EGM Notice’), seeking approval for matters contained in the said Notice. The Notice of the EGM was dispatched to the members of the Company in due compliance with the provisions of the Companies Act, 2013, and rules made thereunder, read with circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. In this regard we would like to mention that regarding Item No. 1 of the aforesaid notice, the Company had (cid:976)iled application with BSE Limited (“BSE”) seeking In-principle approval in relation to the proposed Preferential Issue of Equity Shares for which the approval of the shareholders is being sought. Thereafter, BSE Limited has directed the Company to issue a corrigendum to the Notice giving additional disclosures on appointment of Monitoring Agency. Accordingly, in continuation to the EGM Notice together with the explanatory statement annexed thereto, this corrigendum (“Corrigendum”) is being issued pursuant to and in connection thereof, and same shall be deemed to be an integral part of and should be read in conjunction with the EGM Notice. Pursuant to the Corrigendum, Members are hereby informed and requested to note the following additional disclosure in the explanatory statement to Item No. 1 as set out in the EGM Notice New Para 17 inserted in the explanatory statement: Given that the issue size exceeds INR 100,00,00,000/- (Indian Rupees One Hundred Crore) in terms of Regulation 162A of the SEBI ICDR Regulations, the Company is required to appoint a SEBI registered Credit Rating Agency as the monitoring agency to monitor the use of the proceeds of the preferential issue ("Monitoring Agency"). The Company has appointed Crisil Ratings Limited, a SEBI registered credit rating agency as the Monitoring Agency to monitor the use of proceeds of this preferential issue. All other particulars and details as mentioned in the EGM Notice shall remain unchanged. The Corrigendum shall be read in conjunction with the EGM Notice, together with Explanatory Statement. This Corrigendum is also available on the Company’s website viz. www.bplindia.in , and on the website of the Stock Exchanges at www.bseindia.com. For, Order of Board of Directors, For Bharat Parenterals Limited Sd/- Sharmin Soni Company Secretary and Compliance Officer ICSI Membership No.: A-75694